Cite as: (16 November 2022) Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis. Geert De Vuyst. https://geertdevuyst.be/en/publication/2020-garami-hyperthermia-induced-by-transient-receptor-potential-vanilloid-1-trpv1-antagonists-in-human-clinical-trials/
Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis
Article English Educated
TitleHyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysisAuthor(s)Garami, A., Shimansky, Y. P., Rumbus, Z., Vizin, R. C. L., Farkas, N., Hegyi, J., Szakacs, Z., Solymar, M., Csenkey, A., Chiche, D. A., Kapil, R., Kyle, D. J., Van Horn, W. D., Hegyi, P., & Romanovsky, A. A.JournalPharmacology & TherapeuticsVolume208Year of publication2020Pages107474DOIhttps://doi.org/10.1016/j.pha ... PublisherElsevier BVCite asGarami, A., Shimansky, Y. P., Rumbus, Z., Vizin, R. C. L., Farkas, N., Hegyi, J., Szakacs, Z., Solymar, M., Csenkey, A., Chiche, D. A., Kapil, R., Kyle, D. J., Van Horn, W. D., Hegyi, P., & Romanovsky, A. A. (2020). Hyperthermia induced by transient receptor potential vanilloid‑1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta‑analysis. Pharmacology & Therapeutics, 208, 107474. https://doi.org/10.1016/j.pharmthera.2020.107474